Jan 10, 2020 / 09:30PM GMT
Operator
Greetings. Welcome to the OncoCyte conference call to discuss the agreement to acquire Insight Genetics. (Operator Instructions) Please note this conference is being recorded.
I will now turn the conference over to your host, Ronnie Andrews, Chief Executive Officer. Mr. Andrews, you may begin.
Ronald A. Andrews - OncoCyte Corporation - CEO, President & Director
Yes. Bob, you need to go first.
Robert A. Yedid - LifeSci Advisors, LLC - MD
Yes. Why don't I start? Why don't I start? It's Bob Yedid from LifeSci Advisors. And before Ronnie starts, and I hate to cut him off there, we're just going to read some forward-looking statement. And thank you, operator, and thanks, everyone, for joining us for today's conference call to discuss the definitive agreement to acquire Insight Genetics. If you have not seen today's press release, please visit OncoCyte's website at www.oncocyte.com. In addition, there will be slides that will accompany this
OncoCyte Corp to Acquire Insight Genetics Inc - Conference Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot